Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards, St. Jude Pursue Opposite Pricing Strategies For New Tissue Valves

This article was originally published in The Gray Sheet

Executive Summary

St. Jude Medical does not expect a significant price premium for its BioCor and Epic porcine tissue heart valves upon U.S. approval, anticipated in 2004 and 2006, respectively, the firm says

You may also be interested in...



St. Jude ICD, Tissue Valve Differentiation Will Fall To Incoming CEO Starks

Incoming Chairman and CEO Daniel Starks will direct St. Jude Medical's efforts to catch up with established players in the tissue valve and cardiac resynchronization therapy defibrillator markets

St. Jude ICD, Tissue Valve Differentiation Will Fall To Incoming CEO Starks

Incoming Chairman and CEO Daniel Starks will direct St. Jude Medical's efforts to catch up with established players in the tissue valve and cardiac resynchronization therapy defibrillator markets

MCRI On-X Looks To Revive Mechanical Heart Valve Market

Preliminary data demonstrating whether MCRI's On-X mechanical heart valve can be used with minimal anti-coagulation therapy will be available in the second or third quarter of 2004, the firm says

Related Content

UsernamePublicRestriction

Register

MT019360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel